These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14634398)

  • 1. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?
    Lam JS; Desai M; Mansukhani MM; Benson MC; Goluboff ET
    J Urol; 2003 Dec; 170(6 Pt 1):2288-91. PubMed ID: 14634398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer?
    Lam JS; Sclar JD; Desai M; Mansukhani MM; Benson MC; Goluboff ET
    J Urol; 2004 Nov; 172(5 Pt 1):1856-9. PubMed ID: 15540738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
    Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
    Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
    Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
    J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
    Eastham JA; Carver B; Katz J; Kattan MW
    Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
    Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
    Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
    Lam JS; Cheung YK; Benson MC; Goluboff ET
    J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do concerns about more advanced pathological features increase the likelihood of neurovascular bundle resection in black men undergoing radical prostatectomy?
    Carver BS; Bozeman CB; Venable DD; Eastham JA
    J Urol; 2004 Feb; 171(2 Pt 1):700-2. PubMed ID: 14713790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.
    Kang JS; Maygarden SJ; Mohler JL; Pruthi RS
    BJU Int; 2004 Jun; 93(9):1207-10. PubMed ID: 15180606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.
    Salomon L; Hoznek A; Lefrère-Belda MA; Bellot J; Chopin DK; Abbou CC
    Eur Urol; 2000 Mar; 37(3):297-300. PubMed ID: 10720855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
    Guerrios-Rivera L; Howard LE; Klaassen Z; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Freedland SJ
    Urology; 2021 Mar; 149():181-186. PubMed ID: 33189734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
    Sundi D; Kryvenko ON; Carter HB; Ross AE; Epstein JI; Schaeffer EM
    J Urol; 2014 Jan; 191(1):60-7. PubMed ID: 23770146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.